$14.31
1.027.67%
At close: -
$14.50
0.191.33%
After Hours: Nov 22, 6:09 PM EDT
10x Genomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of 10x Genomics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-29 | $-0.30 | $-0.34 | 11.8 % |
Jun 2024 | 2024-08-08 | $-0.32 | $-0.47 | 31.9 % |
Mar 2024 | 2024-04-30 | $-0.50 | $-0.50 | 0.00 % |
Dec 2023 | 2024-02-15 | $-0.24 | $-0.36 | 33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-29 | $151.65M | $158.63M | -4.40 % |
Jun 2024 | 2024-08-08 | $153.10M | $150.74M | 1.57 % |
Mar 2024 | 2024-04-30 | $141.01M | $142.24M | -0.87 % |
Dec 2023 | 2024-02-15 | $183.98M | $182.80M | 0.64 % |
10x Genomics (TXG) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on October 29, 2024 for Q3.
The Actual EPS was $-0.30, which beat the estimate of $-0.34.
The Actual Revenue was $151.7M, which missed the estimate of $158.6M.
Browse earnings estimates, EPS, and revenue on all stocks.